This is a broad coordinated program combining work in the fields of drug development, biochemical pharmacology, and cancer biology to generate new scientific information with direct and practical relevance for use in man. A significant feature of the proposed program is the collaborative interdisciplinary approach that will result in an efficient mechanism for translating basic scientific information through clinical investigators to practicing physicians, and provide an effective feedback from the clinic to the laboratory as well. A fundamental objective is to seek basic information that will contribute to clinical utilization in human cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA020892-12
Application #
3092897
Study Section
Cancer Therapeutics Program Project Review Committee (CTR)
Project Start
1985-09-30
Project End
1989-06-30
Budget Start
1987-06-01
Budget End
1989-06-30
Support Year
12
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Roger Williams Hospital
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
02908
Abushanab, E; Sarma, M S (1989) 1',2'-seco-dideoxynucleosides as potential anti-HIV agents. J Med Chem 32:76-9
Posner, M R; Ferrari, L; Belliveau, J F et al. (1987) A phase I trial of continuous infusion cisplatin. Cancer 59:15-8
Wiemann, M C; Dexter, D L; Calabresi, P (1987) Artificial capillary culture studies of human tumor cell growth, differentiation, and marker production. J Natl Cancer Inst 79:93-102